André Zimerman

906 total citations · 1 hit paper
41 papers, 398 citations indexed

About

André Zimerman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, André Zimerman has authored 41 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in André Zimerman's work include Heart Failure Treatment and Management (9 papers), Lipid metabolism and disorders (7 papers) and Cardiac pacing and defibrillation studies (6 papers). André Zimerman is often cited by papers focused on Heart Failure Treatment and Management (9 papers), Lipid metabolism and disorders (7 papers) and Cardiac pacing and defibrillation studies (6 papers). André Zimerman collaborates with scholars based in United States, Brazil and Canada. André Zimerman's co-authors include Luís Eduardo Paim Rohde, Sabina A. Murphy, Marc S. Sabatine, Robert P. Giugliano, Nicholas Marston, Brian A. Bergmark, Sotirios Tsimikas, Veronica J. Alexander, Thomas A Prohaska and Ewa Karwatowska‐Prokopczuk and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

André Zimerman

36 papers receiving 391 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk

2024 102 citations Brian A. Bergmark, Nicholas Marston et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André Zimerman United States	10	222	107	77	32	31	41	398
Joanna Lewek Poland	13	184 0.8×	108 1.0×	40 0.5×	40 1.3×	24 0.8×	38	447
Eiji Nozaki Japan	11	97 0.4×	86 0.8×	32 0.4×	18 0.6×	27 0.9×	26	257
Daria Frestad Denmark	12	401 1.8×	154 1.4×	32 0.4×	42 1.3×	14 0.5×	19	568
Sabra C. Lewsey United States	10	227 1.0×	79 0.7×	26 0.3×	44 1.4×	29 0.9×	26	418
Mayank Sardana United States	15	438 2.0×	47 0.4×	21 0.3×	46 1.4×	34 1.1×	39	592
Tobias Täger Germany	14	328 1.5×	66 0.6×	102 1.3×	61 1.9×	51 1.6×	35	484
David Severs Netherlands	11	99 0.4×	48 0.4×	49 0.6×	109 3.4×	24 0.8×	24	361
Carmine Riccio Italy	13	280 1.3×	125 1.2×	41 0.5×	23 0.7×	33 1.1×	76	451
Michael Shen United States	8	221 1.0×	111 1.0×	45 0.6×	21 0.7×	33 1.1×	20	602
A.J. Mourant United Kingdom	7	269 1.2×	136 1.3×	77 1.0×	43 1.3×	35 1.1×	11	448

Countries citing papers authored by André Zimerman

Since Specialization

Citations

This map shows the geographic impact of André Zimerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Zimerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Zimerman more than expected).

Fields of papers citing papers by André Zimerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Zimerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Zimerman. The network helps show where André Zimerman may publish in the future.

Co-authorship network of co-authors of André Zimerman

This figure shows the co-authorship network connecting the top 25 collaborators of André Zimerman. A scholar is included among the top collaborators of André Zimerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Zimerman. André Zimerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimerman, André, Frederick Kamanu, Giorgio Melloni, et al.. (2025). Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic disease. European Journal of Preventive Cardiology.

Rohde, Luís Eduardo Paim, Enrico G. Ferro, Carísi Anne Polanczyk, et al.. (2025). The Southern Brazilian Registry of Atrial Fibrillation (SBR-AF Registry): Predictors of Atrial Arrhythmia Recurrence after First-Time Catheter Ablation. Arquivos Brasileiros de Cardiologia. 122(1). 1 indexed citations

Giugliano, Robert P., André Zimerman, Jonathan Afilalo, et al.. (2025). Outcomes in Older Patients After Switching to a Newer Anticoagulant or Remaining on Warfarin. Journal of the American College of Cardiology. 86(6). 426–439. 3 indexed citations

Marston, Nicholas, Brian A. Bergmark, Veronica J. Alexander, et al.. (2025). Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. American Heart Journal. 286. 125–135. 4 indexed citations

Bergmark, Brian A., Nicholas Marston, Thomas A Prohaska, et al.. (2025). Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial. American Heart Journal. 286. 116–124. 3 indexed citations

Zimerman, André, Eugene Braunwald, Jan Steffel, et al.. (2024). Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation. JAMA Cardiology. 9(9). 817–817. 11 indexed citations

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2024). Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. European Journal of Preventive Cardiology. 31(10). 1216–1223. 8 indexed citations

Zimerman, André, Michelle L. O’Donoghue, Xinhui Ran, et al.. (2024). Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab. NEJM Evidence. 4(1). EVIDoa2400112–EVIDoa2400112. 6 indexed citations

Zimerman, André, et al.. (2023). Papel Incremental da Classificação da New York Heart Association e dos Índices do Teste de Exercício Cardiopulmonar para Prognóstico na Insuficiência Cardíaca: um Estudo de Coorte. Arquivos Brasileiros de Cardiologia. 120(11). e20230077–e20230077. 2 indexed citations

10.

Zimerman, André, et al.. (2023). Incidence of contrast-associated acute kidney injury: a prospective cohort. Brazilian Journal of Nephrology. 46(2). e20230019–e20230019. 1 indexed citations

11.

Zimerman, André, Anderson Donelli da Silveira, Scott D. Solomon, & Luís Eduardo Paim Rohde. (2023). NYHA Classification for Decision-Making in Heart Failure: Time to Reassess?. European Journal of Heart Failure. 25(7). 929–932. 10 indexed citations

12.

Clarke, John‐Ross D., et al.. (2023). Speech-induced atrial tachycardia: A narrative review of putative mechanisms implicating the autonomic nervous system. Heart Rhythm O2. 4(9). 574–580. 1 indexed citations

13.

Zimerman, André, Anderson Donelli da Silveira, Luiz Eduardo Fonteles Ritt, et al.. (2023). Functional Assessment Based on Cardiopulmonary Exercise Testing in Mild Heart Failure: A Multicentre Study. ESC Heart Failure. 10(3). 1689–1697. 8 indexed citations

14.

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2023). Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3. Journal of clinical lipidology. 18(2). e261–e268. 6 indexed citations

15.

Zimerman, André, Michelle L. O’Donoghue, Xinhui Ran, et al.. (2023). Abstract 14714: Long-Term Neurocognitive Safety of LDL-C Lowering With Evolocumab: Open-Label Extension Data From FOURIER. Circulation. 148(Suppl_1). 2 indexed citations

16.

Araújo, Gustavo Neves de, Guilherme Pinheiro Machado, André Zimerman, et al.. (2021). Comparison of Admission Lung Ultrasound and Left Ventricular End-Diastolic Pressure in Patients Undergoing Primary Percutaneous Coronary Intervention. Circulation Cardiovascular Imaging. 14(4). e011641–e011641. 7 indexed citations

17.

Kochi, Adriano Nunes, André Zimerman, Michael Éverton Andrades, et al.. (2021). Growth/differentiation factor-15 (GDF-15) as a predictor of serious arrhythmic events in patients with nonischemic dilated cardiomyopathy. Journal of Electrocardiology. 70. 19–23. 8 indexed citations

18.

Zimerman, André, Carísi Anne Polanczyk, Marciane Maria Rover, et al.. (2020). Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II. Heart. 107(18). 1487–1492. 11 indexed citations

19.

Scolari, Fernando Luís, Marciane Maria Rover, Marcely Gimenes Bonatto, et al.. (2020). Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study. BMC Cardiovascular Disorders. 20(1). 496–496. 27 indexed citations

20.

Rohde, Luís Eduardo Paim, Marciane Maria Rover, José Albuquerque de Figueiredo Neto, et al.. (2019). Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial. European Heart Journal. 40(44). 3605–3612. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact